Home Equities Score What was behind the sudden rise in the stock price of Creative...

What was behind the sudden rise in the stock price of Creative Medical Technology Holdings (CELZ)?

In the last session, Creative Medical Technology Holdings (OTC – CELZ) opened its trading at 0.0238 and closed at $0.0278, an increase of 44.79%. There were 415,117,372 shares traded in the last session compared with 98,568,509 shares during the previous 30 days. Moreover, the most recent 52-week price range for the stock was from $0.0013 to$0.105.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

So, what was behind this rush…


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


On the last day of the troublesome year 2020, In a preclinical study, Creative Medical Technology Holdings Inc. recently reported positive results using ImmCelz to treat a model of a heart attack.

Read More

Ex Vivo reprogrammed immune cells are used as a treatment for heart failure and post-infarct pathological remodeling of mice with restricted blood flow, which will significantly improve survival compared to controls.

Amit Patel, CEO of the company and co-inventor of a patent on the immune system, said that it is “no exaggeration” that the immune system is involved in numerous different aspects of regenerative medicine. “Today’s preliminary results support the notion that a “regenerative immunotherapy” referred to as ImmCelz could be used across a broad spectrum of conditions.”

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Drs Thomas Ichim and Amit Patel have spent decades of work developing the ImmCelz product. It involves the extraction of patient immune cells, incubation with regenerative cells outside of the body, and reinfusion of the patient’s cells. Its results to date have demonstrated the effectiveness of ImmCelz for the treatment of strokes and liver failure.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Drove The STRATA Skin Sciences, Inc. (NASDAQ: SSKN) Stock In Extended Trading?

Shares of dermatology-focused company STRATA Skin Sciences, Inc. (NASDAQ: SSKN) leapt 15.03% to $1.99 in the trading after ring of the bell on Monday....

Why Sundial Growers (SNDL) shares have skyrocketed in intraday trading?

Shares of Sundial Growers (SNDL) have been on a skywalk. As of 10:47 AM EST, the seller, and producer of Cannabis products recorded $1.38...

What Caused 35% Pre-Market Surge In electroCore, Inc. (ECOR) Stock Today?

Shares of electroCore, Inc. (ECOR) has been surging strongly in the pre-market session today following an announcement of exclusive distribution agreement in Australia. The...

Zix Corp (ZIXI) Stock Surged 7% After-Hour For What Reason?

The stock of email security solution provider Zix Corp (ZIXI) has added 7.05% to its value in the after-hours trading on Friday. The company...

Apple Inc. (AAPL) Stocks dip but future prospects for the company seem very positive

On Thursday, Apple shares (NASDAQ: AAPL) closed at $120.99 which is 3.5% lower. In the after-hours session, the price further declined by 0.2%.  The...

Here’s What You Should Know About Just Energy Group Inc (JE) Stock

Just Energy Group Inc (JE)‎ stock has shown a rise in the last trading session. JE is a natural gas and electricity retailer based...

ASLAN Pharmaceuticals (ASLN) Stock sees 70% stock price increase due to successful first trial report

ASLAN Pharmaceuticals (NASDAQ: ASLN) moved upward an impressive 73.58% and has reached a share price of $7.69. ASLAN had previously closed at $4.43. This...

What’s Bringing The Fibrogen (FGEN) Stock Down 23% Pre-Market Today?

The biopharmaceutical company FibroGen, Inc. (FGEN) has been seeing its stock’s price falling 23.81% in pre-market trading today. The decline came following sharing of...

Related News

ASLAN Pharmaceuticals (ASLN) Stock sees 70% stock price increase due to successful first trial report

ASLAN Pharmaceuticals (NASDAQ: ASLN) moved upward an impressive 73.58% and has reached a share price of $7.69. ASLAN had previously closed at $4.43. This...

Shares of XPeng Inc (XPEV) are facing a Decline. Why did this happen?

Shares of Xpeng (XPEV) Inc, the manufacturer and seller of smart electric vehicles in China, are facing a decline in pre-market trading today. The...

Apollo Endosurgery (APEN)’s recent breakthrough can revolutionize the health of NASH patients

Apollo Endosurgery Inc (APEN) is a biotech company, focusing on the product design, establishment, and commercialization of medical-related machinery. The company’s target market includes...

Why The9 Limited (NCTY) Took A 12.64% Leap After-Hours?

Shares of the China based internet company The9 Limited (NCTY) leapt 12.64% in extended trading on Monday. In the absence of any significant news,...

Zix Corp (ZIXI) Stock Surged 7% After-Hour For What Reason?

The stock of email security solution provider Zix Corp (ZIXI) has added 7.05% to its value in the after-hours trading on Friday. The company...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.